TP53 and cancer: Clinically, a large number of malignant tumors that are p53‐negative or mutant, such as liver, 68 lung 69, esophageal, 70 rectal, 71 ovarian, 72 bladder, 73 and skin 74 tumors, exhibit wild‐type TAp73 overexpression.